|
|
||||||||
Pediatric Heart Lung Center and Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado 80262
As observed with nitric oxide (NO), carbon monoxide (CO) binds and may activate soluble guanylate cyclase and increase cGMP levels in smooth muscle cells in vitro. Because inhaled NO (INO) causes potent and sustained pulmonary vasodilation, we hypothesized that inhaled CO (ICO) may have similar effects on the perinatal lung. To determine whether ICO can lower pulmonary vascular resistance (PVR) during the perinatal period, we studied the effects of ICO on late-gestation fetal lambs. Catheters were placed in the main pulmonary artery, left pulmonary artery (LPA), aorta, and left atrium to measure pressure. An ultrasonic flow transducer was placed on the LPA to measure blood flow to the left lung. After baseline measurements, fetal lambs were mechanically ventilated with a hypoxic gas mixture (inspired O2 fraction < 0.10) to maintain a constant fetal arterial PO2. After 60 min (baseline), the lambs were treated with ICO [5-2,500 parts/million (ppm)]. Comparisons were made with INO (5 and 20 ppm) and combined INO (5 ppm) and ICO (100 and 2,500 ppm). We found that ICO did not alter left lung blood flow or PVR at any of the study doses. In contrast, low-dose INO decreased PVR by 47% (P < 0.005). The combination of INO and ICO did not enhance the vasodilator response to INO. To determine whether endogenous CO contributes to vascular tone in the fetal lung, zinc protoporphyrin IX, an inhibitor of heme oxygenase, was infused into the LPA in three lambs. Zinc protoporphyrin IX had no effect on baseline PVR, aortic pressure, or the pressure gradient across the ductus arteriosus. We conclude that ICO does not cause vasodilation in the near-term ovine transitional circulation, and endogenous CO does not contribute significantly to baseline pulmonary vascular tone or ductus arteriosus tone in the late-gestation ovine fetus.
nitric oxide; heme oxygenase; persistent pulmonary hypertension of the newborn; pulmonary hypertension
This article has been cited by other articles:
![]() |
O. V. Evgenov, F. Ichinose, N. V. Evgenov, M. J. Gnoth, G. E. Falkowski, Y. Chang, K. D. Bloch, and W. M. Zapol Soluble Guanylate Cyclase Activator Reverses Acute Pulmonary Hypertension and Augments the Pulmonary Vasodilator Response to Inhaled Nitric Oxide in Awake Lambs Circulation, October 12, 2004; 110(15): 2253 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Naik and B. R. Walker Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1436 - L1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Coceani Carbon Monoxide in Vasoregulation : The Promise and the Challenge Circ. Res., June 23, 2000; 86(12): 1184 - 1186. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |